Conestoga Capital Advisors reported a 3.46% net-of-fees return in Q2 2025, trailing the Russell Mid Cap Growth Index’s 18.20% return. Investor enthusiasm shifted towards high-beta and AI stocks after the “Liberation Day” announcements, posing challenges for the Mid Cap Strategy. Review the fund’s top 5 holdings for insights into their key selections for 2025.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops products for veterinary, livestock, and water testing markets. One-month return was 5.38%, with shares gaining 19.58% over the last 52 weeks. On July 25, 2025, IDXX closed at $565.19 per share, with a market cap of $45.454 billion. Conestoga Capital Advisors praised IDXX’s solid earnings and maintained guidance for high-single-digit organic revenue growth.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) reported 5% organic revenue growth in Q1 2025. 51 hedge fund portfolios held IDXX at the end of Q1, down from 58 in the previous quarter. While IDXX has potential, certain AI stocks offer greater upside potential with less downside risk. Check out a free report on the best short-term AI stock.

Read more at Yahoo Finance: IDEXX Laboratories (IDXX) Rallied in Q2. Here’s Why